Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
28th Dec 18 Source: CRO
- €2.9 billion turnover
-
-€3.6 billion
profit - 3,517 employees
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
- 2 more years available »
Ranking
By Turnover
(€2.9 billion)- 39th in Top Companies
By Employees
(3,517)- 66th in Top Companies
- 3,517
- €2.9 billion
Employees
- David Keenan Vice President}
Latest News
- 9:26pm US stocks end quarter down 20% in biggest drop since 2008
- 8:56pm Communicorp cuts pay by up to 25% at its radio stations
- 8:39pm Covid-19: Builders cease work on big developments
- 7:02pm Moody’s: State is ‘resilient’ enough to cope with the cost of Covid-19
- 7:02pm Ireland ‘resilient’ enough to cope with cost of Covid-19, Moody’s says